Residual Disease Driven Strategy for CARCIK (CD19) in Adults/Pediatric BCP-ALL
NCT05252403
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Acute Lymphoblastic Leukemia
Interventions
GENETIC:
PTG-CARCIK-CD19
Sponsor
Fondazione Matilde Tettamanti Menotti De Marchi Onlus